𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FDA’S Perspectives on Cardiovascular Devices

✍ Scribed by Eric A. Chen; Sonna M. Patel-Raman; Kathryn O’Callaghan; Matthew G. Hillebrenner

Book ID
107639421
Publisher
Springer US
Year
2009
Tongue
English
Weight
89 KB
Volume
2
Category
Article
ISSN
1937-5387

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NHLBI/FDA conference on thrombosis and i
NHLBI/FDA conference on thrombosis and infections with cardiovascular devices
✍ Berson, Alan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## NHLBI/FDA conference on thrombosis and infections with cardiovascular devices BACKGROUND Thrombosis, thromboembolism, and infections remain important complications when artificial hearts and ventricular assist devices are used. These events often develop in a clinically silent fashion, being det

FDA perspective on clinical trial design
FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices
✍ Jennifer Goode; Wolf Sapirstein; Bram Zuckerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The article by Rocha-Singh et al. [1]. on behalf of the VIVA Physicians Incorporate (VPI) in this issue of the Catheterization and Cardiac Interventions addresses the challenge to designing clinical trials for devices intended to correct femoropopliteal arterial insufficiency. As discussed in this a